Cytomegalovirus-induced tubulointerstitial nephritis in a renal allograft treated by foscarnet therapy.
We report a female patient suffering from cytomegalovirus (CMV)-induced tubulointerstitial nephritis in a renal allograft 70 days after a cadaveric renal transplantation. CMV-induced renal allograft injury reported in the literature mainly related to immune-mediated mechanisms. In our patient, acute tubulointerstitial nephritis, associated with histological evidence of CMV infection, was demonstrated in the renal allograft biopsy. There were no histological features of allograft rejection, cyclosporin nephrotoxicity nor 'CMV glomerulopathy'. She was successfully treated by foscarnet therapy and a reduction in immunosuppression. Her renal function returned to baseline afterwards.
Wong
K M
KM
Renal Unit, Department of Medicine, Queen Elizabeth Hospital, Hong Kong. wongkm@hotmail.com
Chan
Y H
YH
Chan
S K
SK
Mak
C K
CK
Chau
K F
KF
Li
C S
CS
D000328:Adult; D000998:Antiviral Agents / Q000627:therapeutic use*; D003586:Cytomegalovirus Infections / Q000150:complications* / Q000188:drug therapy*; D005260:Female; D017245:Foscarnet / Q000627:therapeutic use*; D006801:Humans; D016030:Kidney Transplantation; D009395:Nephritis, Interstitial / Q000188:drug therapy* / Q000821:virology*
D000998:Antiviral Agents; D017245:Foscarnet